Factors Influencing Survival Status of HIV/AIDS after HAART in Huzhou City, Eastern China

Background. Highly active antiretroviral therapy (HAART) can effectively reduce the risk of death and opportunistic infections in patients with HIV/AIDS. The aim of this study was to analyse the survival status and its influencing factors in HIV/AIDS after HAART. Methods. The data on patients’ socio...

Full description

Saved in:
Bibliographic Details
Main Authors: Meihua Jin, Zhongrong Yang, Jing Li, Xiaoqi Liu, Zhenqian Wu
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2022/2787731
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548644650221568
author Meihua Jin
Zhongrong Yang
Jing Li
Xiaoqi Liu
Zhenqian Wu
author_facet Meihua Jin
Zhongrong Yang
Jing Li
Xiaoqi Liu
Zhenqian Wu
author_sort Meihua Jin
collection DOAJ
description Background. Highly active antiretroviral therapy (HAART) can effectively reduce the risk of death and opportunistic infections in patients with HIV/AIDS. The aim of this study was to analyse the survival status and its influencing factors in HIV/AIDS after HAART. Methods. The data on patients’ sociodemographic characteristics, treatment information, and follow-up results from the Information Management System of the Chinese Center for Disease Control and Prevention were obtained. Bivariate and stepwise multivariate Cox proportional hazards regression model analyses were performed. Results. A total of 1812 participants were included in this study, of which 1716 were still alive (survival group) and 96 had died (death group). The results indicated that respondents who were elderly (HR = 1.053, 95% CI: 1.037–1.069, P<0.01), who had heterosexual transmission (HR = 2.422, 95% CI: 1.314–4.465, P<0.01) and whose current WHO clinical stage was stage III or IV (HR = 2.399, 95% CI: 1.215–4.735, P<0.05) were more likely to have died; respondents whose baseline CD4+ T-lymphocyte count was equal to or more than 200 cells/μL (HR = 0.412, 95% CI: 0.275–0.616, P<0.05) were unlikely to have died. Conclusions. It is recommended that HAART be provided to HIV/AIDS patients at an early clinical stage and that the health services for HIV/AIDS patients after taking medicines be strengthened, which will help promote adherence to therapeutic regimens and improve quality of life.
format Article
id doaj-art-e57c02000ed8410ba32bb9d9477d5ba3
institution Kabale University
issn 1918-1493
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-e57c02000ed8410ba32bb9d9477d5ba32025-02-03T06:13:35ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1918-14932022-01-01202210.1155/2022/2787731Factors Influencing Survival Status of HIV/AIDS after HAART in Huzhou City, Eastern ChinaMeihua Jin0Zhongrong Yang1Jing Li2Xiaoqi Liu3Zhenqian Wu4Huzhou Center for Disease Control and PreventionHuzhou Center for Disease Control and PreventionHuzhou Center for Disease Control and PreventionHuzhou Center for Disease Control and PreventionHuzhou Center for Disease Control and PreventionBackground. Highly active antiretroviral therapy (HAART) can effectively reduce the risk of death and opportunistic infections in patients with HIV/AIDS. The aim of this study was to analyse the survival status and its influencing factors in HIV/AIDS after HAART. Methods. The data on patients’ sociodemographic characteristics, treatment information, and follow-up results from the Information Management System of the Chinese Center for Disease Control and Prevention were obtained. Bivariate and stepwise multivariate Cox proportional hazards regression model analyses were performed. Results. A total of 1812 participants were included in this study, of which 1716 were still alive (survival group) and 96 had died (death group). The results indicated that respondents who were elderly (HR = 1.053, 95% CI: 1.037–1.069, P<0.01), who had heterosexual transmission (HR = 2.422, 95% CI: 1.314–4.465, P<0.01) and whose current WHO clinical stage was stage III or IV (HR = 2.399, 95% CI: 1.215–4.735, P<0.05) were more likely to have died; respondents whose baseline CD4+ T-lymphocyte count was equal to or more than 200 cells/μL (HR = 0.412, 95% CI: 0.275–0.616, P<0.05) were unlikely to have died. Conclusions. It is recommended that HAART be provided to HIV/AIDS patients at an early clinical stage and that the health services for HIV/AIDS patients after taking medicines be strengthened, which will help promote adherence to therapeutic regimens and improve quality of life.http://dx.doi.org/10.1155/2022/2787731
spellingShingle Meihua Jin
Zhongrong Yang
Jing Li
Xiaoqi Liu
Zhenqian Wu
Factors Influencing Survival Status of HIV/AIDS after HAART in Huzhou City, Eastern China
Canadian Journal of Infectious Diseases and Medical Microbiology
title Factors Influencing Survival Status of HIV/AIDS after HAART in Huzhou City, Eastern China
title_full Factors Influencing Survival Status of HIV/AIDS after HAART in Huzhou City, Eastern China
title_fullStr Factors Influencing Survival Status of HIV/AIDS after HAART in Huzhou City, Eastern China
title_full_unstemmed Factors Influencing Survival Status of HIV/AIDS after HAART in Huzhou City, Eastern China
title_short Factors Influencing Survival Status of HIV/AIDS after HAART in Huzhou City, Eastern China
title_sort factors influencing survival status of hiv aids after haart in huzhou city eastern china
url http://dx.doi.org/10.1155/2022/2787731
work_keys_str_mv AT meihuajin factorsinfluencingsurvivalstatusofhivaidsafterhaartinhuzhoucityeasternchina
AT zhongrongyang factorsinfluencingsurvivalstatusofhivaidsafterhaartinhuzhoucityeasternchina
AT jingli factorsinfluencingsurvivalstatusofhivaidsafterhaartinhuzhoucityeasternchina
AT xiaoqiliu factorsinfluencingsurvivalstatusofhivaidsafterhaartinhuzhoucityeasternchina
AT zhenqianwu factorsinfluencingsurvivalstatusofhivaidsafterhaartinhuzhoucityeasternchina